
LINZESS Receives FDA Approval for Functional Constipation Treatment in Children Aged 2 and Older
LINZESS® (linaclotide) Receives FDA Approval for Children Aged 2 and Older with Functional Constipation Ironwood Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved an expanded indication…













